Study of a new lung treatment for people with COPD
Part of Lungs & breathing clinical trials.
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have a history of smoking at least 10 pack-years (e.g., 1 pack a day for 10 years).
- You have not smoked or used any inhaled substances (including vaping or cannabis) for at least 2 months and agree to stay smoke-free during the study.
- You have moderate to severe COPD confirmed by breathing tests, and you are on daily inhaled medications.
- You are willing to undergo a bronchoscopy (a scope through the mouth to the lungs) and follow all study procedures, including taking extra medications like prednisone and azithromycin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a bronchoscopic treatment that uses radiofrequency energy to reduce COPD symptoms. It may help people who still have breathing problems despite taking medication.
This study tests a minimally invasive procedure using a small tube through the mouth to treat chronic bronchitis and reduce flare-ups. It might help people with COPD who still have symptoms on their current medicines.
This trial tests whether breathing in nitric oxide gas can improve how well your lungs exchange oxygen and carbon dioxide. It may help people with mild or moderate COPD, and also includes healthy volunteers for comparison.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This trial tests a portable device that delivers gentle air pressure to help you breathe easier. It is for people with severe COPD (chronic obstructive pulmonary disease) who want to see if this device can improve their breathing and daily life.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.